Novartis reported $6.67B in Stock for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Amgen AMGN:US $ 4554M 143M
Biogen BIIB:US $ 1294.2M 78.8M
Bristol Myers Squibb BMY:US $ 2142M 38M
Canopy Growth Corp WEED:CN C$ 205.51M 1.13M
Catalent CTLT:US $ 697M 9M
Corcept Therapeutics CORT:US $ 17.42M 12.34M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Endo International Ordinary Shares ENDP:US $ 287.76M 3.93M
Gilead Sciences GILD:US $ 2587M 88M
GlaxoSmithKline GSK:LN 4664M 1339M
JAZZ PHA JAZZ:US $ 861.7M 123.75M
Lannett LCI:US $ 95.43M 10.34M
Novartis NOVN:VX SF 6880M 117M
Pacira Pharmaceuticals PCRX:US $ 100.59M 3.07M
Perrigo Ordinary Shares PRGO:US $ 1079.6M 57.2M
Phibro Animal Health PAHC:US $ 249.91M 19.13M
Prestige Brands PBH:US $ 133.77M 13.43M
Supernus Pharmaceuticals SUPN:US $ 84.86M 3.94M
Valeant Pharmaceuticals VRX:CN $ 1045M 52M
Zoetis ZTS:US $ 2205M 148M